Dr. Naresh Kumar Trehan
#243Chairman and Managing Director
79
Age
57y
Exp
16y
Tenure
7/10
Risk
🎓 MBBS · King George Medical University, Lucknow
📜 Diploma Cardiothoracic Surgery · American Board of Cardiothoracic Surgery
🏛️ None
CompensationTBP
Personality
7
Open
9
Cons
6
Extr
6
Agre
2
Neur
Global Health
Healthcare · Large Cap
High Growth · Founder-Centric
About
Dr. Naresh Kumar Trehan is the Chairman and Managing Director of Global Health, a Large Cap company in the Healthcare sector with a market cap of ₹29K Cr. A Transformational leader with 57 years of experience, he is known for authority-driven decision-making and organic builder strategy. His career is defined by the high-stakes creation and scaling of the Medanta hospital network, demonstrating extreme surgical precision and institutional ambition.
FAQ
What is Dr. Naresh Kumar Trehan's leadership style?
Dr. Naresh Kumar Trehan is classified as a Transformational leader. He is authority-driven in decision-making, with a nation builder motivation and steady-marathon pace of execution.
What is Dr. Naresh Kumar Trehan's educational background?
Dr. Naresh Kumar Trehan holds a MBBS from King George Medical University, Lucknow and a Diploma Cardiothoracic Surgery from American Board of Cardiothoracic Surgery.
Who is the CEO of Global Health?
Dr. Naresh Kumar Trehan is the Chairman and Managing Director of Global Health. He has been with the company for 16 years and in the current role for 16 years.
Leadership DNA
ArchetypeTransformational
MotivationNation Builder
CrisisSteady Hand
DecisionAuthority-Driven
GrowthOrganic Builder
PeopleInstitution Builder
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerPremium-Niche
EmployerTalent Magnet
BrandTechnical-Expert
FocusProduct Innovation
OrientationDeep Specialist
Leadership Evidence
“His career is defined by the high-stakes creation and scaling of the Medanta hospital network, demonstrating extreme surgical precision and institutional ambition.”
⚡ Crisis●●●●○
Throughout the COVID-19 pandemic, Dr. Trehan maintained operational continuity and clinical standards at Medanta without pivoting away from the core mission of high-end tertiary care.
🎯 Motivation●●●●●
Dr. Trehan returned to India from the US specifically to establish world-class healthcare infrastructure, culminating in the creation of the Medanta - The Medicity model to reduce medical tourism.
👥 People●●●●○
He has focused on building a robust ecosystem of specialized medical training and clinical research, positioning Medanta as a premier training ground for surgeons and specialists in India.
📈 Growth●●●●●
Global Health's growth has been primarily driven by the development and scaling of large-scale, multi-specialty 'Medicity' campuses across India rather than aggressive M&A.
💡 Innovation●●●●○
Medanta excels at scaling advanced clinical protocols and medical technologies pioneered globally into the Indian multi-specialty hospital ecosystem.
🏃 Pace●●●●○
The hospital chain follows a methodical, long-term strategy of capacity expansion and bed-count growth across tier-1 and tier-2 cities.
🌱 Purpose●●●●○
The company integrates high-end clinical care with significant CSR initiatives focused on medical outreach and community health programs.
🏷️ Brand●●●●●
Medanta is defined by its institutional focus on complex surgeries, organ transplants, and specialized clinical outcomes.
🤝 Customer●●●●●
Medanta positions itself as a destination for complex, high-acuity medical procedures, catering to an affluent and health-conscious demographic.
💼 Employer●●●●○
The brand's reputation for clinical excellence and its association with Dr. Trehan makes it a premier destination for top-tier medical consultants and specialists.
📋 Mandate
Continued growth requires rapid scaling of hospital infrastructure and clinical footprints across new high-potential geographies.
🏢 Culture●●●●○
Strong influence of Dr. Naresh Trehan on the medical vision and operational oversight.
Financials
Revenue FY25₹4K Cr
PAT FY25₹481 Cr
Rev CAGR 5Y18.8%
OPM20.3%
NPM13.2%
ROE14.2%
ROCE17.8%
P/E56.2
Fwd P/E41.3
P/B7.8
D/E25.5
Promoter67.5%
Institutional21.7%
Mkt Cap₹29K Cr
Compensation
To Be Published
Data being verified from audited reports
